These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
857 related articles for article (PubMed ID: 11781619)
1. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Theilgaard-Mönch K; Raaschou-Jensen K; Palm H; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 2001 Dec; 28(11):1073-82. PubMed ID: 11781619 [TBL] [Abstract][Full Text] [Related]
2. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162 [TBL] [Abstract][Full Text] [Related]
3. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255 [TBL] [Abstract][Full Text] [Related]
4. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood. Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996 [TBL] [Abstract][Full Text] [Related]
5. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts. Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266 [TBL] [Abstract][Full Text] [Related]
6. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both. Ho AD; Young D; Maruyama M; Corringham RE; Mason JR; Thompson P; Grenier K; Law P; Terstappen LW; Lane T Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228 [TBL] [Abstract][Full Text] [Related]
7. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report. Cairo MS; Wagner EL; Fraser J; Cohen G; van de Ven C; Carter SL; Kernan NA; Kurtzberg J Transfusion; 2005 Jun; 45(6):856-66. PubMed ID: 15934982 [TBL] [Abstract][Full Text] [Related]
8. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection. Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543 [TBL] [Abstract][Full Text] [Related]
9. [CD34 cells and T cell subsets in recombinant human granulocyte colony-stimulating factor primed bone marrow grafts from donors with different characteristics]. Chang YJ; Zhao XY; Huo MR; Luo XH; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):512-6. PubMed ID: 19112912 [TBL] [Abstract][Full Text] [Related]
10. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model. Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672 [TBL] [Abstract][Full Text] [Related]
12. Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions. Huang XJ; Chang YJ; Zhao XY Transpl Immunol; 2007 Apr; 17(3):193-7. PubMed ID: 17331846 [TBL] [Abstract][Full Text] [Related]
13. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation. Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion. Silva MR; Parreira A; Ascensão JL Exp Hematol; 1995 Dec; 23(14):1676-81. PubMed ID: 8542964 [TBL] [Abstract][Full Text] [Related]
15. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor. Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278 [TBL] [Abstract][Full Text] [Related]
16. A unique population of CD34+ cells in cord blood. Nimgaonkar MT; Roscoe RA; Persichetti J; Rybka WB; Winkelstein A; Ball ED Stem Cells; 1995 Mar; 13(2):158-66. PubMed ID: 7540469 [TBL] [Abstract][Full Text] [Related]
17. Flow cytometric assessment of hematopoietic cell subsets in cryopreserved preterm and term cord blood, influence of obstetrical parameters, and availability for transplantation. Cervera A; Lillo R; García-Sánchez F; Madero L; Madero R; Vicario JL Am J Hematol; 2006 Jun; 81(6):397-410. PubMed ID: 16680748 [TBL] [Abstract][Full Text] [Related]
18. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation]. Han XH; Shi YK; He XH; Yang JL; Liu P Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):47-50. PubMed ID: 12678987 [TBL] [Abstract][Full Text] [Related]
19. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation. De Bruyn C; Delforge A; Lagneaux L; Bron D Bone Marrow Transplant; 2000 Feb; 25(4):377-83. PubMed ID: 10723580 [TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]